Is a complete BCDA research report available?

No complete published report is available for BioCardia, Inc. (BCDA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BioCardia, Inc. (BCDA)

NASDAQ: BCDA · USD

$0.85

-0.05 (-6.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BCDA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.7M
Net income (ttm)	-7.8M
EPS (ttm)	-$0.95
Shares out	11.4M
Volume	129,816
Beta	0.44
Price target	$15.5	+1723.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7.8M
EPS (ttm): -$0.95
Market cap: 9.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BCDA indicators

Market & fundamental data

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000925741
Company name	BioCardia, Inc.
Country	United States
Country code	US
Cusip	09060U606
Employees	21
Employees Change	1%
Employees Change Percent	5
Enterprise value	$9.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US09060U6064
Last refreshed	2026-07-25
Market cap	$9.7M
Market cap category	Nano-Cap
Price	$0.85
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2836
Symbol	BCDA
Website	https://www.biocardia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-77.22%
FCF yield	-74.36%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-4.7M
Net Income	$-7.8M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Profit Per Employee	$-370,238
ROA	-252
Roa5y	-101.3
ROCE	733.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.6%
Cagr3y	-69.4%
Cagr5y	-56.67%
EPS Growth Quarters	11
EPS Growth Years	7
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$1.7M
Cash	$951,000
Current Assets	$1.1M
Current Liabilities	$2.8M
Debt	$412,000
Equity	$-1.1M
Liabilities	$2.8M
Long Term Assets	$572,000
Long Term Liabilities	$0
Net Cash	$539,000
Net Cash By Market Cap	$5.35
Net Cash Growth	444.44%
Tangible Book Value	$-1.1M
Tangible Book Value Per Share	$-0.1
WACC	6.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.41
Net Working Capital	$-2.2M
Quick ratio	0.35
Working Capital	$-1.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-135.69%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.58%
200-day SMA	1.2
3Y total return	-97.14%
50-day SMA	0.96
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.47%
All Time High	2,073.6
All Time High Change	-99.96%
All Time High Date	2016-12-29
All Time Low	0.78
All Time Low Change	9.48%
All Time Low Date	2026-06-11
ATR	0.1
Beta	0.44
Beta1y	-0.69
Beta2y	1.28
Ch YTD	-31.99
High	0.91
High52	2.42
High52 Date	2025-07-24
High52ch	-64.87%
Low	0.85
Low52	0.78
Low52 Date	2026-06-11
Low52ch	9.48%
Ma50ch	-11.19%
Premarket Change Percent	-2.76
Premarket Price	$0.88
Premarket Volume	909
Price vs 200-day SMA	-28.92%
RSI	41.34
RSI Monthly	35.96
RSI Weekly	39.17
Sharpe ratio	-0.98x
Sortino ratio	-1.27
Total Return	-135.69%
Tr YTD	-31.99
Tr1m	-14.99%
Tr1w	2.94%
Tr3m	-27.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$25
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.19
Operating Income	$-7.8M
Price target	$15.5
Price Target Change	$1,723
Price Target Change Top	$2,841

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,515,538%
Float Percent	74.86%
Shares Insiders	22.05%
Shares Institutions	13.26%
Shares Out	11,374,724
Shares Qo Q	1.27%
Shares Yo Y	135.69%
Short Float	4.37%
Short Ratio	0.04
Short Shares	3.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.9M
Average Volume	473,292.45x
Bv Per Share	-0.1
CAPEX	$-10,000
Ch1m	-14.99
Ch1w	2.94
Ch1y	-64.58
Ch3m	-27.34
Ch3y	-97.14
Ch5y	-98.47
Ch6m	-36.56
Change	-6.07%
Change From Open	-5.54
Close	0.91
Days Gap	-0.55
Depreciation Amortization	15,000
Dollar Volume	110,356.6
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-7.8M
EBITDA	$-7.8M
EPS	$-0.95
F Score	2
FCF	$-7.5M
FCF EV Yield	-78.56x
FCF Per Share	$-0.66
Financing CF	7,489,000
Fiscal Year End	December
Investing CF	-10,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2024-05-30
Last Split Type	Reverse
Last10k Filing Date	2026-03-24
Ma150	1.14
Ma150ch	-25.1%
Ma20	0.99
Ma20ch	-13.93%
Net CF	2,000
Next Earnings Date	2026-08-10
Open	0.9
Optionable	No
Position In Range	0.17
Post Close	0.85
Postmarket Change Percent	0.11
Postmarket Price	$0.85
Ppne	401,000
Pre Close	0.91
Price Date	2026-07-24
Relative Volume	0.27x
Share Based Comp	373,000
Tr6m	-36.56%
Us State	California
Volume	129,816

BioCardia, Inc. (BCDA)

Coverage state: Market snapshot only — no published research

Generate the first BCDA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BCDA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCDA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BCDA

Frequently asked questions